J. de Ruyter “Toto” C. Oroceo, President and General Manager of Delex Pharma International Inc. (DPII), and his team discuss the company’s rapid growth in the Philippines since 2013, the key areas driving success for the company as well as their plans to venture into manufacturing and expanding their business globally.
To begin, what have been some of the biggest changes here at Delex Pharma since we last spoke with you in 2013?
"There are indeed gaps in the market as most MNCs consider the market here too small to bring needed, specialized products."
